Skip to content

All Lessons

Selective Safety Data Collection in Clinical Trials (REdI 2024 – Drugs Track)

Session 1: Panel Discussion (FDA Generic Drug Science Workshop 2025)

Session 1: Presentations (FDA Generic Drug Science Workshop 2025)

Session 1: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 1: Scientific and Regulatory Considerations for In Vitro Release Test (IVRT) for Complex Products

Session 2: Panel Discussion (FDA Generic Drug Science Workshop 2025)

Session 2: Presentations (FDA Generic Drug Science Workshop 2025)

Session 2: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 2: Research to Support Guidance Development for Topical Drug Products

Session 3: Panel Discussion (FDA Generic Drug Science Workshop 2025)

Session 3: Presentations (FDA Generic Drug Science Workshop 2025)

Session 3: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 3: Research to Support Guidance Development for Inhalation Drug Products

Session 4: Outlook for Drug-Device Combination Products

Session 4: Panel Discussion (FDA Generic Drug Science Workshop 2025)

Session 4: Presentations (FDA Generic Drug Science Workshop 2025)

Session 4: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 5: Panel Discussion (FDA Generic Drug Science Workshop 2025)

Session 5: Presentations (FDA Generic Drug Science Workshop 2025)

Session 5A: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 5A: Spotlight Generic Drug Review Challenges and Solutions

Session 5B: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 5B: Spotlight Generic Drug Review Challenges and Solutions

Session 6: Ensuring Efficient and Consistent High Quality Generic Drug Development

Session 6: Question & Answer Panel (Advancing Generic Drug Development 2024)

1 … 9 10 11 12 13
Share: